Tirzepatide vials is a prescription drug for injection, mainly used for weight management and blood sugar control in patients with type 2 diabetes. The product works by simulating two intestinal hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which can enhance insulin secretion, inhibit gastric emptying, and effectively control appetite, thereby helping patients lower blood sugar and lose weight. Tirzepatide adopts a once-weekly injection regimen, with a starting dose of usually 2.5 mg, which is gradually increased according to the patient's tolerance and efficacy, up to 15 mg.
| Product Name | Tirzepatide Peptide |
| Shelf Life | 2 Years |
| Form | Peptide |
| Indication | Weight Loss |
| Dosage | 2.4mg/week |
| Active Ingredient | Tirzepatide |
| Storage Conditions | Store At 2-25°C |
| Packaging | 5mg/vial, 10mg/vial, 15mg/vial, 20mg/vial, 30mg/vial, 40mg/vial, 60mg/vial |
Tirzepatide vials contain a medication used primarily for the treatment of type 2 diabetes and chronic weight management. The active ingredient, tirzepatide, is a dual incretin receptor agonist that mimics the effects of two natural gut hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
1. Improves Blood Sugar Control:
Stimulates insulin secretion in response to high blood sugar.
Reduces glucagon levels, which helps lower blood glucose.
2. Promotes Weight Loss:
Suppresses appetite and reduces food intake.
Delays gastric emptying, helping patients feel fuller for longer.
3. Supports Weekly Dosing:
Tirzepatide is administered once a week, providing convenient and sustained blood sugar and weight management.
4. Used in Obese or Overweight Adults:
Particularly beneficial for adults with obesity or overweight who have at least one weight-related health condition, such as high blood pressure or high cholesterol.
For high value products, please select air shipping and express delivery for safety.
